Journal profile · ONCOLOGY
Breast Cancer Management
ISSN 1758-1923 · eISSN 1758-1931 · Future Medicine Ltd · United Kingdom
Breast Cancer Management: fully open access; APC about USD 1,415; review about 13 weeks (community reports); 0 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Breast Cancer Management is published by Future Medicine Ltd. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and BRCA gene mutations in cancer, together about 52.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology29%
- Breast Lesions and CarcinomasMedicine14.9%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology9.1%
- Cancer survivorship and careMedicine4.2%
- Advanced Breast Cancer TherapiesMedicine4.2%
- HER2/EGFR in Cancer ResearchMedicine3.2%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology3.2%
- Women's cancer prevention and managementMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | Q3 | 247/361 | 31st |
| Oncology | Q3 | 309/428 | 27th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
Early warning / risk: Marked as ceased in ESCI on 20 June 2024. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.21LetPub ·
- SNIP 2026-06
- 0.27LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 39OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 4LetPub ·
Articles by year OpenAlex count · 342 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 53 |
| 2025 | 0 | 0 | 93 |
| 2024 | 0 | 0 | 114 |
| 2023 | 5 | 5 | 106 |
| 2022 | 6 | 6 | 105 |
| 2021 | 7 | 7 | 114 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 13 weeksLetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,415 | — | — | |
| LetPub | USD 1,415 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Future Medicine Ltd
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1758-1923
- Electronic ISSN
- 1758-1931
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Breast Cancer Management
How long does peer review take at Breast Cancer Management?
Authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Breast Cancer Management?
According to LetPub and DOAJ records, Breast Cancer Management is indexed in Scopus.
Is Breast Cancer Management open access, and what is the APC?
Breast Cancer Management is a fully open-access journal. APC about USD 1,415.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .